However, it is important to understand that 24 weeks, while substantial for clinical trials, provides limited information about safety with years-long continuous use
There is no fixed conversion
The best B12 injection schedule depends on your health needs and how you react to the treatment
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Medications such as metformin or proton pump inhibitors can significantly hinder B12 absorption
Patients who are deficient in vitamin B12 may receive these shots to help with their chronic fatigue, difficulty losing weight, brain fog, and more